You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PHENAPHEN W/ CODEINE NO. 4 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Phenaphen W/ Codeine No. 4 patents expire, and what generic alternatives are available?

Phenaphen W/ Codeine No. 4 is a drug marketed by Robins Ah and is included in one NDA.

The generic ingredient in PHENAPHEN W/ CODEINE NO. 4 is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Phenaphen W/ Codeine No. 4

A generic version of PHENAPHEN W/ CODEINE NO. 4 was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27th, 2019.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PHENAPHEN W/ CODEINE NO. 4?
  • What are the global sales for PHENAPHEN W/ CODEINE NO. 4?
  • What is Average Wholesale Price for PHENAPHEN W/ CODEINE NO. 4?
Summary for PHENAPHEN W/ CODEINE NO. 4
Drug patent expirations by year for PHENAPHEN W/ CODEINE NO. 4

US Patents and Regulatory Information for PHENAPHEN W/ CODEINE NO. 4

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Robins Ah PHENAPHEN W/ CODEINE NO. 4 acetaminophen; codeine phosphate CAPSULE;ORAL 084446-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.